Short Interest in Decibel Therapeutics, Inc. (NASDAQ:DBTX) D

Decibel Therapeutics, Inc. (NASDAQ:DBTX – Get Rating) saw a significant decrease in short interest in the month of April. As of April 30th, there was short interest totalling 155,500 shares, a decrease of 5.9% from the April 15th total of 165,300 shares. Currently, 1.3% of the shares of the stock are short sold. Based on […]

Related Keywords

United States , America , , Nasdaq , Dimensional Fund Advisors , America Corp , Tower Research Capital , Decibel Therapeutics Company Profile , Decibel Therapeutics Inc , Renaissance Technologies , York Mellon Corp , Decibel Therapeutics , Get Rating , Research Capital , New York Mellon Corp , Gene Therapies , Monogenic Hearing Loss , Hair Cell Regeneration , Otoprotection Therapeutic , Decibel Therapeutics Daily , Nasdaq Dbtx , Dbtx , Medical , Stocks , Options , Put , Call ,